技術指標
指標
數值
方向
MACD(12,26,9)
-0.151
賣出
RSI(14)
31.775
中性
STOCH(KDJ)(9,3,3)
7.990
超賣
ATR(14)
0.266
低波動
CCI(14)
-107.670
賣出
Williams %R
95.556
超賣
TRIX(12,20)
-0.834
賣出
StochRSI(14)
0.000
超賣
搜尋
LifeMD Inc
LFMD添加自選
3.500USD
-0.140-3.85%
收盤 07-31 16:00（美東）報價延遲15分鐘
169.27M總市值
51.74本益比TTM
關鍵數據
3.620今開
3.685最高
573.08K成交量
51.74本益比TTM
27.58本益比動
--股利TTM
1.21%換手率
3.640昨收
3.440最低
1.46M成交額
虧損本益比靜
11.06市淨率
0.00%股息率 TTM
-24.29%ROA
15.84052週最高
0.73量比
-21.99M淨利潤
47.53M總股本
0.0677每股盈餘TTM
2.01Beta
-315.30%ROE
2.56052週最低
6.73%振幅
88.19%毛利率
169.27M總市值
-5.67回報/風險
4.56%風險率
TradingKey LifeMD Inc股票評分
單位: USD 更新時間: 2026-07-31操作建議
LifeMD Inc當前公司基本面數據相對健康，增長潛力很大。當前估值合理，在醫療設備與耗材行業排名83/199位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為9.88。中期看，股價處於下降通道。近一個月，市場表現非常差，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
LifeMD Inc評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
中性
LifeMD Inc亮點
亮點風險
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
業績高增長
公司營業收入穩步增長，連續3年增長27.21%
業績轉盈
公司業績轉盈，最新年度盈利美元
估值高估
公司最新PE估值51.74，處於3年歷史高位
機構減倉
最新機構持股20.73M股，環比減少22.97%
ETHSX持倉
明星投資者ETHSX持倉，最新持倉101.46K股
分析師目標
基於
8
分析師
買入
評級
9.875
目標均價
+182.14%
漲幅空間
LifeMD Inc新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
8
分析師
買入
評級
9.875
目標均價
+182.14%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
88
總數
4
中位數
7
平均值
公司名稱
評級分佈
分析師數
LifeMD Inc
LFMD
8
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
18
技術指標
移動平均線
指標
數值
方向
MA5
3.698
賣出
MA10
3.836
賣出
MA20
4.233
賣出
MA50
4.435
賣出
MA100
4.311
賣出
MA200
4.148
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
LifeMD Inc簡介
LifeMD, Inc. is a provider of virtual healthcare services and pharmacy services. The Company offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across 200 conditions, including primary care, men’s and women’s health, mental health, and weight management. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. In addition, the Company is focused on developing its Rex MD product portfolio, which is primarily focused on asynchronous men’s healthcare, e-pharmacy solutions, and men’s hormonal health. The Company owns a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated compounding pharmacy, and a United States based patient care center.
公司代碼LFMD
公司LifeMD Inc
CEOSchreiber (Justin)
網址https://lifemd.com/
公司股東
相關品種
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%熱門品種
52757.700
+379.700 (+0.72%)
28489.200
+328.300 (+1.17%)
7530.600
+55.500 (+0.74%)
14603.000
-146.000 (-0.99%)
63798.000
+946.000 (+1.50%)
6399.800
+34.400 (+0.54%)
78.082
-7.852 (-9.14%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4064.880
+23.450 (+0.58%)
常見問題
LifeMD Inc(LFMD)的當前股價是多少？
LifeMD Inc(LFMD)的當前股價是 3.50。
LifeMD Inc 的股票代碼是什麼？
LifeMD Inc的股票代碼是LFMD。
LifeMD Inc股票的52週最高點是多少？
LifeMD Inc股票的52週最高點是15.84。
LifeMD Inc股票的52週最低點是多少？
LifeMD Inc股票的52週最低點是2.56。
LifeMD Inc的市值是多少？
LifeMD Inc的市值是169.27M。
現在LifeMD Inc(LFMD)的股票是買入、持有還是賣出？
根據分析師評級，LifeMD Inc(LFMD)的總體評級為買入，目標價格為9.88。
LifeMD Inc(LFMD)股票的每股收益（EPS TTM）是多少
LifeMD Inc(LFMD)股票的每股收益（EPS TTM）是0.25。